These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32238278)

  • 1. Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation.
    Ram E; Lavee J; Shechter M; Kogan A; Maor E; Asher E; Freimark D; Klempfner R; Peled Y
    Am J Cardiol; 2020 May; 125(10):1517-1523. PubMed ID: 32238278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation.
    Peled Y; Ram E; Lavee J; Tenenbaum A; Fisman EZ; Freimark D; Klempfner R; Sternik L; Shechter M
    Cardiovasc Diabetol; 2019 Oct; 18(1):132. PubMed ID: 31604444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation.
    Ram E; Lavee J; Tenenbaum A; Klempfner R; Fisman EZ; Maor E; Ovdat T; Amunts S; Sternik L; Peled Y
    Cardiovasc Diabetol; 2019 Sep; 18(1):118. PubMed ID: 31526382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts.
    Berg K; Clemmensen TS; Tram EM; Koefoed-Nielsen P; Ilkjaer LB; Poulsen SH; Eiskjaer H
    Clin Transplant; 2018 Aug; 32(8):e13343. PubMed ID: 29974979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?
    Khoury M; Conway J; Gossett JG; Edens E; Soto S; Cantor R; Koehl D; Barnes A; Exil V; Glass L; Kirklin JK; Zuckerman WA
    J Heart Lung Transplant; 2022 May; 41(5):578-588. PubMed ID: 35172937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Endothelin-1 With Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation.
    Parikh RV; Khush K; Pargaonkar VS; Luikart H; Grimm D; Yu M; Okada K; Honda Y; Yeung AC; Valantine H; Fearon WF
    J Card Fail; 2019 Feb; 25(2):97-104. PubMed ID: 30543947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The policy of placing older donors into older recipients: is it worth the risk?
    Tehrani YS; Yu Z; Luu M; Liou F; Rafiei M; Hamilton M; Kobashigawa JA
    Clin Transplant; 2014 Jul; 28(7):802-7. PubMed ID: 24801014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight gain post-heart transplantation is associated with an increased risk for allograft vasculopathy and rejection.
    Ram E; Klempfner R; Peled A; Kassif Y; Sternik L; Lavee J; Peled Y
    Clin Transplant; 2021 Mar; 35(3):e14187. PubMed ID: 33314309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved long-term outcomes after heart transplantation utilizing donors with a traumatic mode of brain death.
    Ram E; Lavee J; Freimark D; Maor E; Kassif Y; Sternik L; Kogan A; Peled Y
    J Cardiothorac Surg; 2019 Jul; 14(1):138. PubMed ID: 31331354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-recipient ethnic mismatching impacts short- and long-term results of heart transplantation.
    Peled Y; Loewenthal R; Kassif Y; Raichlin E; Younis A; Younis A; Nachum E; Freimark D; Goldenberg I; Lavee J
    Clin Transplant; 2018 Oct; 32(10):e13389. PubMed ID: 30144324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients.
    Asleh R; Briasoulis A; Pereira NL; Edwards BS; Frantz RP; Daly RC; Lerman A; Kushwaha SS
    J Heart Lung Transplant; 2018 Nov; 37(11):1372-1380. PubMed ID: 30174165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.
    Peled Y; Lavee J; Raichlin E; Katz M; Arad M; Kassif Y; Peled A; Asher E; Elian D; Har-Zahav Y; Shlomo N; Freimark D; Goldenberg I; Klempfner R
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28990263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
    Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
    J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of heart transplantation in patients with human immunodeficiency virus.
    Madan S; Patel SR; Saeed O; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    Am J Transplant; 2019 May; 19(5):1529-1535. PubMed ID: 30614612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in preformed panel-reactive antibody levels and outcomes in patients undergoing heart transplantation.
    Magnussen C; Ruebsamen N; Ojeda FM; Rybczynski M; Kobashigawa J; Reichenspurner H; Bernhardt AM; Schnabel RB
    Clin Transplant; 2019 Jun; 33(6):e13572. PubMed ID: 31012162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of mean first-year heart rate on outcomes after heart transplantation: does it make a difference?
    Shah AB; Patel JK; Rafiei M; Morrissey RP; Kittleson MM; Kobashigawa JA
    Clin Transplant; 2013; 27(5):659-65. PubMed ID: 23924048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and dyslipidemia predict cardiac allograft vasculopathy and graft loss in children and adolescents post-heart transplant: A PHTS multi-institutional analysis.
    Bogle C; Cantor R; Koehl D; Lochridge J; Kirklin JK; Barnes A; Wallis G; Amdani S; Ameduri R; Pahl E; Simpson KE; Blume ED
    Pediatr Transplant; 2022 Aug; 26(5):e14244. PubMed ID: 35122464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods.
    Kransdorf EP; Loghmanpour NA; Kanwar MK; Temkit MH; Stehlik J
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.